Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells
about
The metabolic advantage of tumor cellsPancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminaseArginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy.Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivationProteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.Arginine increases development of in vitro-produced porcine embryos and affects the protein arginine methyltransferase-dimethylarginine dimethylaminohydrolase-nitric oxide axis.Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth.Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas.Arginine deprivation as a targeted therapy for cancer.TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivationUse of a Plackett-Burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells.Molecular basis and current strategies of therapeutic arginine depletion for cancer.Arginine dependence of tumor cells: targeting a chink in cancer's armor.Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment.A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas.L-arginine biosensors: A comprehensive review.
P2860
Q21245765-1E5F983C-17E6-4C37-8604-FF7CE6AE842AQ28288793-3371975A-FC44-41DA-A6E5-39A8143DC5D4Q34314481-74177674-8AB1-4A8D-9E68-2300377017B3Q34497105-204469B9-CD39-4837-9298-612717C41578Q34568337-524D2FF0-7CB9-41DD-957E-F59151037452Q35170154-C3B26320-B119-4DD6-9F6A-AEA3C3C26238Q36501368-697F9574-21A8-4E35-B7C5-51167976F300Q36671753-C2D81B63-04BD-4173-8745-664BAB9A6F63Q36873800-42411CCE-7C8C-41B4-A2F4-090434D72212Q37160927-223A73A5-9534-4BBF-98D2-6EA958B0E460Q37167357-25094D19-39E9-4977-885A-A0E378FC9D77Q37929098-8DF90112-8D74-422C-8DF3-52F8A7D14443Q38749541-671F465E-871D-478B-862F-AFAF3595BBB8Q38816145-1D5BF99E-92D1-40FA-9BFD-14AB2B376CFEQ39823199-0EFE03BE-F64F-4329-98D6-DB1E0D57C3EEQ39935779-D46AD715-258A-42D3-B749-F98925FDDC03Q40188863-94F31A00-9E6B-444E-B6BF-3B8917183A7BQ40739842-E516ADC8-4896-44D7-91BF-D5DF51016C16Q42324345-C4AEDBEC-C5DD-4660-B52E-3707AE8BE0E2Q44565671-430CAAAB-BA17-4528-9770-31580D12D45B
P2860
Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Arginine deprivation, growth i ...... citrulline by malignant cells
@en
type
label
Arginine deprivation, growth i ...... citrulline by malignant cells
@en
prefLabel
Arginine deprivation, growth i ...... citrulline by malignant cells
@en
P2860
P356
P1476
Arginine deprivation, growth i ...... citrulline by malignant cells
@en
P2093
Campbell E
Wheatley DN
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601134
P407
P577
2003-08-01T00:00:00Z
P5875
P6179
1045268284